AOD 9604
GH derived peptide fragment (optimized analogue)
Informational content • Not medical advice • For research purposes only
Overview
Selective peripheral metabolic modulation.
GH derived peptide fragment (optimized analogue)
Selective peripheral metabolic modulation.
Mechanism of action
For non experts: AOD 9604 is best described as a GH fragment research peptide developed to probe fat metabolism signaling, with mixed and limited clinical translation relative to mainstream approved obesity medications.
Evidence includes animal studies where GH C terminal fragments influenced lipolysis (fat breakdown) and fat oxidation, and broader obesity pharmacotherapy reviews have discussed AOD 9604 as an experimental anti obesity approach. However, it is not widely recognized as an approved anti obesity drug in major regulatory markets, and claims should remain conservative and evidence based.
AOD 9604 is a modified peptide derived from the C terminal region of human growth hormone (hGH), commonly described in the literature as an analogue of the hGH fragment (177–191). It was designed to explore whether a GH derived fragment could influence fat metabolism pathways without acting like full growth hormone (notably, some studies report it does not interact with the classic GH receptor).
Authenticity
To validate your product, scan the QR code on the packaging or open the verification page for this product group.